SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-1.77%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$180M
AUM Growth
+$180M
(+2.2%)
Cap. Flow
+$8.72M
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
37.35%
Holding
45
New
7
Increased
15
Reduced
13
Closed
4
Top Buys
| 1 |
Waters Corp
WAT
|
$4.04M |
| 2 |
Revvity
RVTY
|
$3.01M |
| 3 |
Baxter International
BAX
|
$2.96M |
| 4 |
HCA Healthcare
HCA
|
$2.76M |
| 5 |
Biogen
BIIB
|
$2.67M |
Top Sells
| 1 |
Sanofi
SNY
|
$3.75M |
| 2 |
Charles River Laboratories
CRL
|
$3.21M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
$3.12M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$3.07M |
| 5 |
Humana
HUM
|
$2.43M |
Sector Composition
| 1 | Healthcare | 99.5% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Encompass Health
EHC
$12.5B
| $3.85M | 2.14% |
85,000
+20,000
| +31% | +$149K |
|
27
Option Care Health
OPCH
$4.7B
| $3.46M | 1.92% |
110,000
+10,000
| +10% | +$315K |
|
28
Surgery Partners
SGRY
$2.89B
| $3.24M | 1.8% |
138,609
+63,509
| +85% | +$1.49M |
|
|
29
Revvity
RVTY
$9.68B
| $3.01M | 1.67% |
+25,000
| New | +$3.01M |
|
30
Abbott
ABT
$230B
| $2.9M | 1.61% |
30,000
-10,000
| -25% | -$968K |
|
31
Select Medical
SEM
$1.6B
| $2.87M | 1.6% |
130,000
+40,000
| +44% | +$884K |
|
|
32
Biogen
BIIB
$20.8B
| $2.67M | 1.48% |
+10,000
| New | +$2.67M |
|
33
Medtronic
MDT
$118B
| $2.42M | 1.35% |
30,000
-10,000
| -25% | -$808K |
|
34
Avantor
AVTR
$8.74B
| $1.96M | 1.09% |
100,000
| – | – |
|
35
IQVIA
IQV
$31.4B
| $1.81M | 1.01% |
10,000
-7,500
| -43% | -$1.36M |
|
36
Royalty Pharma
RPRX
$15.8B
| $1.81M | 1% |
+45,008
| New | +$1.81M |
|
|
AMED
37
DELISTED
Amedisys
AMED
| $1.69M | 0.94% |
+17,500
| New | +$1.69M |
|
|
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.37M | 0.76% |
10,000
| – | – |
|
39
Incyte
INCY
$17B
| $1.25M | 0.69% |
+18,755
| New | +$1.25M |
|
|
40
SPDR S&P Biotech ETF
XBI
$5.29B
| $895K | 0.5% |
11,284
-38,716
| -77% | -$3.07M |
|
41
Enhabit
EHAB
$398M
| $879K | 0.49% |
+62,594
| New | +$879K |
|
|
LHCG
42
DELISTED
LHC Group LLC
LHCG
| – | – |
-20,000
| Closed | -$3.12M |
|
|
43
Sanofi
SNY
$122B
| – | – |
-75,000
| Closed | -$3.75M |
|
44
Grifois
GRFS
$6.53B
| – | – |
-100,000
| Closed | -$1.19M |
|
|
45
Charles River Laboratories
CRL
$7.99B
| – | – |
-15,000
| Closed | -$3.21M |
|